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Background: Oral lichen planus (OLP) is a premalignant mucocutaneous disease that affects 1-2% of the adult 
population. Immunological factor may act as etiological factor. The cellular immune cells such as T cells are 
important in pathogenesis of OLP. Interleukin-4 (IL-4) is secreted by T-helper 2 (Th2). Several studies have been 
carried out on the role of IL-4 in OLP. The aim of this study was to review the level of IL-4 in OLP, effective 
factors in the production of IL-4 and its role in the development of OLP.
Material and Methods: A search in PubMed was performed on the literature published from 2000 until august 
2019 using the following keywords: “oral lichen planus” or “OLP” and “interleukin-4” or “IL-4”.
Results: Originally, 37 articles were considered, of which 28 case-control articles were selected according to the 
inclusion/exclusion criteria.
Conclusions: This review study shows that IL-4 plays a key role in the development of OLP. According to the 
past studies, there are several factors contributing to the production of this cytokine. Identification of the routes of 
production of IL-4 and its role in OLP might be useful for development of new preventive and therapeutic methods 
in management of patients with OLP.
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Introduction
Oral lichen planus (OLP) is recognized as a chronic in-
flammatory disease with other systemic disorders. Its 
prevalence ranges from 1% to 2% among the general 
population. It often involves middle-aged patients and is 
more common in women than in men (1,2). Although the 
etiology of OLP is unknown, various mechanisms have 
been suggested to be involved in its pathogenesis (spe-
cific immune response to antigens, immune response, 
humoral immunity, and nonspecific mechanisms). OLP 
is a T-cell-induced autoimmune disorder in which CD8 
+ cells can induce apoptosis in oral epithelial cells. T 
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States MEDLINE was used as search source. The key-
words were selected based on Medical Subject Heading 
(MeSH) terms. The studies were retrieved by searching 
the key terms “oral lichen planus” or “OLP” and “inter-
leukin-4” or “IL-4” in PubMed databases from 2000 up 
to august 2019.
- Study selection and selection criteria
A protocol was used for establishment of the inclusion 
and exclusion criteria. The studies on the association be-
tween OLP and IL-4 were selected without restrictions 
of variants of OLP. To select the studies, all obtained 
English language reports were reviewed, and titles and 
abstracts were screened for relevance. Studies were ex-
cluded if they were review or animal studies. Duplicate 
publications (risk of bias), were removed from the study.
- Data extraction
The studies were checked by one author (P.M.) to ex-
tract all the relevant data. Another author (M.A) reeval-
uated the data. Disagreements were resolved with the 
third author’s discussion (S.P.M).
Results
- Study selection
In an initial research, 37 articles were identified through 
electronic database. The full texts of these studies were as-
sessed for eligibility and 9 studies were excluded with rea-
sons (5 studies were review/systematic review, 1 reported 
the polymorphisms of other cytokine, 1 was performed 
on animals, 1 was performed on cutaneous lichen planus 
and 1 study was published in Chinese) that shown in Fig. 1.
helper cells (Th) are traditionally divided into two sub-
groups (Th1 and Th2). Accordingly, impaired immune 
regulation has been implicated in the cause of OLP. Cy-
tokines can play a mediating role between keratinocytes 
and inflammatory cells, and they also play important 
roles in damaging keratinocytes (3-6). Interleukin-4 
(IL-4) is an important cytokine that is responsible for 
the secretion of other cytokines. It plays a central role 
in regulating antibody production and humoral immune 
response to differentiate Th2 cells (7-10). Several stud-
ies have been carried out on the role of IL-4 in OLP. 
Some studies have examined IL-4 levels in the tissues; 
saliva and serum in OLP, and contradictory results have 
been presented. Other studies have examined the factors 
affecting the production of IL-4 and the mechanisms of 
lesions of OLP formation by this cytokine. Our purpose 
in this study has been placed on the levels of IL-4 in 
different samples, production of IL-4 and its role in the 
development of OLP in this review. Identification of the 
routes of production of IL-4 and its role in OLP might be 
useful for development of new preventive and therapeu-
tic methods in management of patients with OLP as well.
Material and Methods
This systematic review was conducted based on the 
Preferred Reporting Items for Systematic reviews and 
Meta-Analyses (PRISMA) statement for reporting sys-
tematic reviews (11).
- Search strategies
The PubMed (MEDLINE) database of the United 
Fig. 1: The PRISMA flowchart of the study selection.
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Finally, 28 studies were evaluated. Of the 28 articles 
evaluated, 14 articles evaluated the IL-4 levels in the 
different samples, which are detailed in Table 1 (12-25); 
nine articles evaluated the effect of different factors on 
the production of IL-4 that also shown in Table 2 (26-
34). One article examined the polymorphism of the IL-4 
gene in patient with lichen planus, one article about the 
amount of IL-4 producing cells; one article examined 
the effect of IL-4 on CD 275+ cells and one article com-
pared IL-4+ T cells levels between OLP and SCC speci-
men. The details of these five studies are shown in the 
Table 3 (35-39).
Author Year Sample Results
Wei 
(12)
2018 Saliva No significant difference in salivary IL-4 between OLP and control groups.
HU JY 
(13)
2015 serum The IL-4 level decreased in erosive OLP group, and was much lower than that of non-
erosive OLP group. It also revealed that the expression of miR-155 in peripheral blood 
might be associated with the levels of IL-4.
Malekzadeh 
(14)




2015 serum & 
tissue






OLP patient showed a high-level IL-4 expression profile in both serum and saliva. Se-
rum IL-4 level in the erythematous/ulcerative group was significantly higher than that 
in the reticular group.
Piccini 
(17)
2014 tissue mRNA expression for IL-4 was significantly higher in erosive OLP compared with their 
tissue controls.
No significant difference was observed in produced IL-4 by CD4+ T-cell clones derived 
from erosive and reticular  lesions.
Ding 
(18)
2014 Serum & 
PBMC
A higher level of IL-4 in PBMC and serum specimen of OLP patients was observed. A 
negative correlation between Golli-MBP (a regulator of autogenic T cells) and IFN-γ /
IL-4 gene expression was observed in PBMCs but not in serum levels of OLP patients.
HU JY 
(19)
2013 Serum The levels of serum IL-4 in OLP patients were apparently lower than that in controls. 








2012 Serum IL-4 levels were significantly lower in OLP patients than in controls. The low serum 




2009 Saliva OLP patient showed a high-level IL-4 expression profile in saliva, With regards to sub-
types, salivary IL-4 level in erythematous/ulcerative group was significantly higher 





In OLP lesions, IL-4 in erythematous ⁄ ulcerated OLP was higher significantly than that 





IL-4 was not found in the blood and epithelium lesional of healthy individuals and those 
with lichen planus HCV-ve, and in blood of OLP HCV+ve patient. but, in epithelium 
lesional of erosive OLP HCV+ve patient weakly present in majority of samples.
Khan 
(25)
2003 Tissue IL-4 secretion were not detected in any OLP-LTL
PBMC:  Peripheral blood mono nuclear cell
PD-1: Programmed death-1 
Table 1: Articles evaluated the IL-4 levels in the different samples.
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Results of studies
Effecting factor in 
IL-4 production in 
patient with OLP
YearAuthour




Exogenous IGF1, rapamycin and LY294002 alone had no effects on the production 
of IL-4. However, when IGF1 co-stimulated with rapamycin or LY294002, the se-





increased levels of IL-4 in keratinocytes were induced by IL-25IL-252019Wang 
(28)
a significant down-regulation of IL-4 secretion by T cells after co-culture with 
exosomes from erosive OLP and non-erosive OLP
Exososome2019Peng 
(29)
IL-4 levels were significantly increased in OLP patients. the acetylation level of 





OLP changed the expression profile of miR-155 and miR-19a, which in turn directly 
affected the production of nitric oxide and TLR2, respectively. The inhibition of 
nitric oxide production and the enhancement in TLR2 expression synergistically 





Serum IL-4 levels were significantly higher in the periostin high group compared 
with the periostin low group of OLP patients
Periostin2018Zhang 
(32)
Myeloid dendritic cells expressing Thymic stromal lymphopoietin receptor (TSL-
PR) contribute to aberrant Th 2 immune responses (IL-4 production) and the patho-
genesis of OLP via TSLP stimulation. 
TSLPR2017Yamauchi 
(33)
The epithelial cells from the saliva of OLP subjects exhibited increased IL-12 and 
IL-4 secretion following LPS stimulation. Furthermore, treatment with dexameth-
asone significantly elevated the IL-4 concentration in the LPS stimulated cultures 
of epithelial cells from the OLP saliva as compared with similarly treated cultures 
of cells from control saliva.




TRIM: tripartite motif-containing protein
IGF1: Insulin-like growth factors 1
miR: MicroRNAs 





2016 OSCC had significantly not more IL-4+ cells, than OLP.  The data thus suggested IL-4 might 
not be important for the immune evasion of OSCC.
Simark-Mattsson 
(36)
2013 the levels of IL-4 were equivalent in PPD-stimulated blood cells,
Suggesting that Th2 responses may be less affected.
Kalogerakou 
(37)




2008 There was no difference between the OLP patient and healthy control groups in frequencies 





2006 IL‐4 induced marked CD275 expression on CD14+ monocytes. In contrast to CD275 induction 
on monocytes, IL‐4 alone did not enhance CD275 on endothelial cells.
PPD: purified protein derivative
Table 2: Articles evaluated the effect of different factors on the production of IL-4.
Table 3: Other lichen planus article.
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Discussion
Although the exact cause of OLP is still unknown, it 
has been widely accepted that immunodeficiency cases 
are very important. The role of Th1 / Th2 imbalance 
in the pathogenesis of OLP has been widely studied 
among several etiologic agents in the Past years (4,7,8). 
Given the expression of Th1 cytokines by T cells in 
OLP lesion lymphocytes and the pathological hypoth-
esis of OLP that Th1-activated auto cytotoxic CD8 T 
cells induce apoptosis of keratinocytes, Sugerman et al. 
suggested that OLP was characterized by Th1 cytokines 
(10). However, concomitant expression of Th1 and Th2 
cytokines is observed in localized OLP lesions and tis-
sue secretions. In addition, saliva, serum, and periph-
eral blood mononuclear cells from OLP patients have a 
complex expression profile of Th1 and Th2 cytokines. 
There is no doubt that both Th1 and Th2 immune re-
sponses are involved in the development of OLP. Inter-
feron gamma (IFN-γ) and IL-4, the most characteristic 
of Th1 and Th2 cytokines, regulate T cell differen-
tiation and Th1 / Th2 balance, respectively, in physi-
ological and pathological immune processes. IFN-γ is 
involved in the maturation and activation of cytotoxic 
CD8 T cells and maintenance of the expression of major 
class II tissue adhesion molecules, thus participating in 
keratinocyte apoptosis and chronic OLP. IL-4 disease, 
on the other hand, for Th2 cell differentiation and it has 
an important role in regulating antibody production and 
humoral immune response (4,7,8).
Table 1 presents contradictory results on the levels of 
IL-4 in different samples. This disagreement may be 
due in part to patient differences, subgroups of OLP, 
research methods, or sample size, but also suggests that 
mechanisms such as the role of T regulatory cells and 
new Th cell subsets may exist, in the etiology of OLP 
except for the Th1 / Th2 imbalance. Another impor-
tant factor to consider is the interaction of genes and 
cytokines as well as the effect of gene polymorphisms 
on cytokine production. Indeed, a study of Chinese 
ethnicity showed that IL-4 gene polymorphism had a 
positive effect on OLP sensitivity and prognosis (38). It 
may therefore explain the differences between results in 
numerous studies. In addition, according to the studies 
in the present review, none of them examined the ef-
fect of age and sex on IL-4 levels, although we believe 
that these factors should be taken into account in future 
studies. The most important point to be drawn from 
these tables is that the levels of interleukin but not its 
secretory cells are higher in most studies in the Lichen 
Planus group than in healthy individuals, thus indicat-
ing that IL-4 may represent a potential salivary bio-
marker for the disease. Taking advantage of easy access 
and noninvasive collection by intermediate-educated 
individuals, whole saliva offers a cost-effective way to 
monitor recurrent diseases and screen large populations 
in studies of Systemic diseases, especially oral diseases, 
which is consistent with a recent systematic review (40). 
In most of these studies, interleukin-4 levels are higher 
in the erosive form than in the reticular type, which may 
be attributed to more inflammation and infection in the 
erosive form, or to the possible role of interleukin in the 
conversion of the reticular to the erosive type through 
impaired keratinocyte repair. Another point to note is 
that the levels of interleukin-4 in HCV-ve are not dif-
ferent from those of HCV+ve, so this cytokine is not an 
important factor in the development of lichen planus in 
hepatitis c-positive individuals (24). Also, the level of 
this cytokine in patients with SCC is lower than in those 
with lichen planus. It can be concluded that interleukin 
is not an important factor in the development of malig-
nancy in lichen planus (35).
Youngnak-Piboonratanakit et al showed that IL-4 in-
duced CD275 expression on monocytes, that is more 
important for Th2 differentiation and effector functions 
then for Th1 responses.
This review study shows that IL-4 plays a key role in 
the development of OLP. According to the past studies, 
there are several factors contributing to the production 
of this cytokine. In addition, IL-4 causes OLP lesions 
through its effect on various cells. It is hoped that this 
review article raises our awareness about the role of 
IL-4 in the etiopathogenesis of lichen planus and open 
up new ways of preventing and treating.
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